Tandem Diabetes Care, Inc. (TNDM): Price and Financial Metrics
GET POWR RATINGS... FREE!
TNDM POWR Grades
- TNDM scores best on the Value dimension, with a Value rank ahead of 73.63% of US stocks.
- The strongest trend for TNDM is in Momentum, which has been heading down over the past 178 days.
- TNDM ranks lowest in Sentiment; there it ranks in the 0th percentile.
TNDM Stock Summary
- Price to trailing twelve month operating cash flow for TNDM is currently 52.61, higher than 92.31% of US stocks with positive operating cash flow.
- With a year-over-year growth in debt of 33.43%, TANDEM DIABETES CARE INC's debt growth rate surpasses 77.35% of about US stocks.
- Over the past twelve months, TNDM has reported earnings growth of -494.89%, putting it ahead of just 3.72% of US stocks in our set.
- Stocks with similar financial metrics, market capitalization, and price volatility to TANDEM DIABETES CARE INC are VRAY, UPWK, LNSR, SMRT, and BLKB.
- Visit TNDM's SEC page to see the company's official filings. To visit the company's web site, go to www.tandemdiabetes.com.
TNDM Valuation Summary
- In comparison to the median Healthcare stock, TNDM's price/sales ratio is 29.79% lower, now standing at 3.3.
- TNDM's price/sales ratio has moved down 17.1 over the prior 112 months.
Below are key valuation metrics over time for TNDM.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| TNDM | 2023-03-17 | 3.3 | 6.0 | -28.1 | -33.5 |
| TNDM | 2023-03-16 | 3.3 | 6.1 | -28.3 | -33.7 |
| TNDM | 2023-03-15 | 3.4 | 6.2 | -28.7 | -34.2 |
| TNDM | 2023-03-14 | 3.4 | 6.2 | -29.0 | -34.5 |
| TNDM | 2023-03-13 | 3.2 | 5.9 | -27.2 | -32.6 |
| TNDM | 2023-03-10 | 3.0 | 5.5 | -25.7 | -30.9 |
TNDM Growth Metrics
- The 4 year revenue growth rate now stands at 374.03%.
- The 2 year price growth rate now stands at 18.36%.
- Its 2 year net income to common stockholders growth rate is now at 135.45%.
The table below shows TNDM's growth in key financial areas (numbers in millions of US dollars).
| Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
|---|---|---|---|
| 2022-12-31 | 801.217 | 50.464 | -94.594 |
| 2022-09-30 | 790.712 | 64.279 | -67.933 |
| 2022-06-30 | 765.792 | 74.48 | -13.169 |
| 2022-03-31 | 737.669 | 96.474 | 5.895 |
| 2021-12-31 | 702.799 | 111.359 | 15.566 |
| 2021-09-30 | 660.868 | 106.961 | 21.758 |
TNDM's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- TNDM has a Quality Grade of C, ranking ahead of 66.11% of graded US stocks.
- TNDM's asset turnover comes in at 0.848 -- ranking 30th of 186 Medical Equipment stocks.
- IVC, TCMD, and PSTV are the stocks whose asset turnover ratios are most correlated with TNDM.
The table below shows TNDM's key quality metrics over time.
| Period | Asset Turnover | Gross Margin | ROIC |
|---|---|---|---|
| 2021-09-30 | 0.848 | 0.534 | 0.036 |
| 2021-06-30 | 0.823 | 0.532 | 0.024 |
| 2021-03-31 | 0.785 | 0.523 | -0.018 |
| 2020-12-31 | 0.849 | 0.522 | -0.045 |
| 2020-09-30 | 0.897 | 0.524 | -0.109 |
| 2020-06-30 | 1.040 | 0.526 | -0.154 |
TNDM Price Target
For more insight on analysts targets of TNDM, see our TNDM price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
| Average Price Target | $132.75 | Average Broker Recommendation | 1.62 (Moderate Buy) |
TNDM Stock Price Chart Interactive Chart >
TNDM Price/Volume Stats
| Current price | $41.61 | 52-week high | $123.96 |
| Prev. close | $41.14 | 52-week low | $33.51 |
| Day low | $40.37 | Volume | 940,186 |
| Day high | $41.95 | Avg. volume | 1,313,821 |
| 50-day MA | $41.21 | Dividend yield | N/A |
| 200-day MA | $48.79 | Market Cap | 2.69B |
Tandem Diabetes Care, Inc. (TNDM) Company Bio
Tandem Diabetes Care, Inc. focuses on the design, development, and commercialization of various products for people with insulin-dependent diabetes in the United States. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. The company was founded in 2006 and is based in San Diego, California.
Latest TNDM News From Around the Web
Below are the latest news stories about TANDEM DIABETES CARE INC that investors may wish to consider to help them evaluate TNDM as an investment opportunity.
Tandem Diabetes Care Announces NEJM Publication of Study Demonstrating Increased Time in Range in Young Children with Type 1 Diabetes Using the t:slim X2 Insulin Pump with Control-IQ TechnologySAN DIEGO, March 15, 2023--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced publication of results from the Pediatric Artificial Pancreas (PEDAP) Clinical Trial by the New England Journal of Medicine showing an approximate 3-hour per day increase in time in range* in children ages 2-5 years old using the t:slim X2 insulin pump with Control-IQ advanced hybrid closed-loop technology** compared to those on a standard insulin pump |
This Stock Could Soar By as Much as 106%, According to Wall StreetSome of Wall Street's predictions seem a bit aggressive, but investors should still consider this company. |
Fair Isaac & Co. Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P MidCap 400 and S&P SmallCap 600 indices effective prior to the open of trading on Monday, March 20, to coincide with the quarterly rebalance. The changes are being made to ensure each index is more representative of its market capitalization range. The company moving to the S&P 500 is more representative of the large-cap market space. All companies moving to the S&P MidCap 400 are more representative of the mid |
12 Most Promising Medical Stocks According to AnalystsIn this article, we will take a look at the 12 most promising medical stocks according to analysts. To see more such companies, go directly to 5 Most Promising Medical Stocks According to Analysts. Regardless of the short-term market situation, the healthcare industry has a huge growth potential. According to a report by McKinsey, healthcare […] |
Tandem Diabetes Care Full Year 2022 Earnings: EPS Misses ExpectationsTandem Diabetes Care ( NASDAQ:TNDM ) Full Year 2022 Results Key Financial Results Revenue: US$801.2m (up 14% from FY... |
TNDM Price Returns
| 1-mo | -0.12% |
| 3-mo | 0.17% |
| 6-mo | -15.34% |
| 1-year | -64.10% |
| 3-year | -16.70% |
| 5-year | 1,024.59% |
| YTD | -7.43% |
| 2022 | -70.14% |
| 2021 | 57.32% |
| 2020 | 60.51% |
| 2019 | 56.99% |
| 2018 | 1,508.90% |
Continue Researching TNDM
Here are a few links from around the web to help you further your research on Tandem Diabetes Care Inc's stock as an investment opportunity:Tandem Diabetes Care Inc (TNDM) Stock Price | Nasdaq
Tandem Diabetes Care Inc (TNDM) Stock Quote, History and News - Yahoo Finance
Tandem Diabetes Care Inc (TNDM) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...